Clinical trial
SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With…
NCT00117052 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00117052 |
|---|---|
| Title | SENSOR: Study to Investigate Cinacalcet Treatment in Haemodialysis Patients With Secondary Hyperparathyroidism |
| Official title | SENSOR: Study to InvestigatE Cinacalcet TreatmeNt in Haemodialysis Patients With SecOndary HyperparathyRoidism |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism, End Stage Renal Disease |
| Intervention type | Drug |
| Interventions | cinacalcet |
| Enrollment | 673 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Jul 4, 2005 |
| Last update posted | May 23, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: